FR2390947A1 - Corps de capsule en particulier pour l'utilisation avec une capsule assemblee pour une preparation pharmaceutique, procede et appareil pour sa fabrication - Google Patents

Corps de capsule en particulier pour l'utilisation avec une capsule assemblee pour une preparation pharmaceutique, procede et appareil pour sa fabrication

Info

Publication number
FR2390947A1
FR2390947A1 FR7814737A FR7814737A FR2390947A1 FR 2390947 A1 FR2390947 A1 FR 2390947A1 FR 7814737 A FR7814737 A FR 7814737A FR 7814737 A FR7814737 A FR 7814737A FR 2390947 A1 FR2390947 A1 FR 2390947A1
Authority
FR
France
Prior art keywords
capsule
capsule body
pharmaceutical preparation
manufacturing
assembled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7814737A
Other languages
English (en)
Other versions
FR2390947B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsugel AG
Original Assignee
Capsugel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsugel AG filed Critical Capsugel AG
Publication of FR2390947A1 publication Critical patent/FR2390947A1/fr
Application granted granted Critical
Publication of FR2390947B1 publication Critical patent/FR2390947B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/077Manufacturing capsule shells
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14Dipping a core
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C69/00Combinations of shaping techniques not provided for in a single one of main groups B29C39/00 - B29C67/00, e.g. associations of moulding and joining techniques; Apparatus therefore
    • B29C69/001Combinations of shaping techniques not provided for in a single one of main groups B29C39/00 - B29C67/00, e.g. associations of moulding and joining techniques; Apparatus therefore a shaping technique combined with cutting, e.g. in parts or slices combined with rearranging and joining the cut parts
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/001Combinations of extrusion moulding with other shaping operations
    • B29C48/0022Combinations of extrusion moulding with other shaping operations combined with cutting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/13Articles with a cross-section varying in the longitudinal direction, e.g. corrugated pipes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29LINDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00Other particular articles
    • B29L2031/712Containers; Packaging elements or accessories, Packages
    • B29L2031/7174Capsules
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S220/00Receptacles
    • Y10S220/34Anti-tamper pharmaceutical capsules, e.g. tamper indicating or resistant
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne le conditionnement des médicaments. Il s'agit d'un corps de capsule ayant pratiquement la forme d'un cylindre ferme à une extrémité, en particulier pour l'utilisation avec une capsule assemblée pour une préparation pharmaceutique et comprenant un corps de capsule et un chapeau de capsule qui y est adapté, caractérisé en ce que le corps de capsule présente un diamètre réduit dans la région de son extrémite ouverte. Ce corps de capsule est utile dans le conditionnement des préparations liquides.
FR7814737A 1977-05-20 1978-05-18 Corps de capsule en particulier pour l'utilisation avec une capsule assemblee pour une preparation pharmaceutique, procede et appareil pour sa fabrication Granted FR2390947A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2722806A DE2722806C2 (de) 1977-05-20 1977-05-20 Kapselkörper für eine Steckkapsel für Arzneimittel oder andere portionsweise zu verpackende Stoffe, sowie Verfahren zu seiner Herstellung

Publications (2)

Publication Number Publication Date
FR2390947A1 true FR2390947A1 (fr) 1978-12-15
FR2390947B1 FR2390947B1 (fr) 1980-04-04

Family

ID=6009457

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7814737A Granted FR2390947A1 (fr) 1977-05-20 1978-05-18 Corps de capsule en particulier pour l'utilisation avec une capsule assemblee pour une preparation pharmaceutique, procede et appareil pour sa fabrication

Country Status (34)

Country Link
US (1) US4247006A (fr)
JP (1) JPS53145908A (fr)
AR (1) AR221842A1 (fr)
AT (1) AT363605B (fr)
AU (1) AU521515B2 (fr)
BE (1) BE867233A (fr)
BG (1) BG31064A3 (fr)
BR (1) BR7803155A (fr)
CA (1) CA1100873A (fr)
CH (1) CH624900A5 (fr)
CS (1) CS205123B2 (fr)
DD (1) DD135469A5 (fr)
DE (1) DE2722806C2 (fr)
DK (1) DK150812C (fr)
EG (1) EG14108A (fr)
ES (3) ES469989A1 (fr)
FI (1) FI68969C (fr)
FR (1) FR2390947A1 (fr)
GB (1) GB1597303A (fr)
GR (1) GR64534B (fr)
HU (1) HU178486B (fr)
IE (1) IE46974B1 (fr)
IT (1) IT1103484B (fr)
MX (1) MX5217E (fr)
NL (1) NL181904C (fr)
NO (1) NO146456C (fr)
PL (1) PL114266B1 (fr)
PT (1) PT68059B (fr)
RO (1) RO84527B1 (fr)
SE (1) SE442166B (fr)
SU (1) SU1127524A3 (fr)
TR (1) TR19872A (fr)
YU (2) YU121678A (fr)
ZA (1) ZA782874B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017148A1 (fr) * 1991-03-28 1992-10-15 Huhtamäki Oy Equipement de fabrication de capsules sous-cutanees
WO1992017147A1 (fr) * 1991-03-28 1992-10-15 Huhtamäki Oy Procede de fabrication de capsules sous-cutanees
US5261211A (en) * 1991-03-28 1993-11-16 Huntamaki Oy Method for manufacturing of subcutaneous capsules

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0110500B1 (fr) * 1982-10-29 1987-06-03 Warner-Lambert Company Capsules inviolables
US4667498A (en) * 1984-06-29 1987-05-26 Sauter Manufacturing Corp. Method and apparatus of making gelatine capsule forming pins having a rounded locking groove
US4758149A (en) * 1984-06-29 1988-07-19 Sauter Manufacturing Co. Capsule forming pin having a burnish-hardened surface
DE3907973A1 (de) * 1989-03-11 1990-09-13 Merck Patent Gmbh Trockenmittel-tablette
ES2181935T3 (es) 1991-05-31 2003-03-01 Scherer Technologies Inc R P Metodo y aparato para fabricar capsulas farmaceuticas de celulosa- dimensionamiento la capsula.
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5769267A (en) * 1995-11-09 1998-06-23 Warner-Lambert Company Container
US5993185A (en) * 1996-03-21 1999-11-30 Farmacapsulas S.A. Deck plate assemblies for forming capsules
US5945136A (en) * 1997-04-03 1999-08-31 Technophar Equipment & Service Limited Heating elevator for capsule making machine
US6000928A (en) * 1997-04-03 1999-12-14 Technophar Equipment & Service Limited Capsule making machine having improved pin bars and air flow characteristics
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US8377471B2 (en) * 2005-08-09 2013-02-19 Capsugel Belgium Nv Container
US20070036830A1 (en) * 2005-08-09 2007-02-15 Stef Vanquickenborne Container
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
WO2011011333A2 (fr) 2009-07-20 2011-01-27 Nanoink, Inc. Nanomoulage d'éléments à l'échelle micronique et nanométrique
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
CA3065589C (fr) * 2010-06-03 2022-04-26 Catalent Ontario Limited Capsules multiphases de gel mou, appareil et procede pour celles-ci
US9744221B2 (en) 2014-12-23 2017-08-29 Synthetic Biologics, Inc. Method and compositions for inhibiting or preventing adverse effects of oral antibiotics
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
WO2019096833A1 (fr) * 2017-11-17 2019-05-23 Evonik Röhm Gmbh Procédé de préparation d'une capsule à coque dure revêtue
US11338020B2 (en) 2018-01-09 2022-05-24 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
MX2020008777A (es) 2018-02-23 2020-11-06 Finch Therapeutics Holdings Llc Inmunoterapias relacionadas con el microbioma.
EP3773686B1 (fr) 2018-03-20 2023-06-07 Theriva Biologics, Inc. Agents au phosphatase alcaline pour le traitement de troubles dus à une exposition à des radiations
FR3085841B1 (fr) * 2018-09-14 2020-12-04 Oreal Procede de preparation de capsules et systeme associe
JP2022547330A (ja) 2019-09-13 2022-11-11 フィンチ セラピューティクス ホールディングス エルエルシー 自閉症スペクトラム障害を治療するための組成物および方法
EP4045630A1 (fr) 2019-10-18 2022-08-24 Finch Therapeutics Holdings LLC Compositions et procédés pour administrer un métabolite bactérien à un sujet
WO2021097288A1 (fr) 2019-11-15 2021-05-20 Finch Therapeutics Holdings Llc Compositions et méthodes de traitement de maladies neurodégénératives
TW202140049A (zh) 2020-01-10 2021-11-01 美商芬奇治療控股有限責任公司 用於治療b型肝炎(hbv)及d型肝炎(hdv)之組合物及方法
WO2021142358A1 (fr) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions et méthodes pour le traitement de l'encéphalopathie hépatique (eh)
WO2021142347A1 (fr) 2020-01-10 2021-07-15 Finch Therapeutics Holdings Llc Compositions et procédés relatifs à la stéatohépatite non alcoolique (nash)
US20230201265A1 (en) 2020-03-31 2023-06-29 Finch Therapeutics Holdings Llc Compositions comprising non-viable fecal microbiota and methods of use thereof
WO2022178294A1 (fr) 2021-02-19 2022-08-25 Finch Therapeutics Holdings Llc Compositions et méthodes pour fournir des acides biliaires secondaires à un sujet

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE655413A (fr) *
CH508398A (de) * 1969-07-11 1971-06-15 Lilly Co Eli Verfahren zur Füllung und Abdichtung von Gelatinekapseln

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US525845A (en) * 1894-09-11 Riley p
US525844A (en) * 1894-09-11 Eiley p
AT10823B (fr) * 1900-11-19 1903-02-25 Otto Krahl
US2936493A (en) * 1955-06-16 1960-05-17 Scherer Corp R P Method of making plastic capsules
US3285408A (en) * 1964-10-16 1966-11-15 Lilly Co Eli Capsule with integral locking band
US3258115A (en) * 1965-05-12 1966-06-28 Scherer Corp R P Two-piece hard gelatin capsule
US3399803A (en) * 1966-10-11 1968-09-03 Parke Davis & Co Self-locking medicament capsule
US3664495A (en) * 1970-12-21 1972-05-23 Parke Davis & Co Locking capsule
US3927195A (en) * 1974-01-31 1975-12-16 Lilly Industries Ltd Production of capsules
US4040536A (en) * 1975-05-05 1977-08-09 R. P. Scherer Corporation Locking hard gelatin capsule
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE655413A (fr) *
CH508398A (de) * 1969-07-11 1971-06-15 Lilly Co Eli Verfahren zur Füllung und Abdichtung von Gelatinekapseln

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992017148A1 (fr) * 1991-03-28 1992-10-15 Huhtamäki Oy Equipement de fabrication de capsules sous-cutanees
WO1992017147A1 (fr) * 1991-03-28 1992-10-15 Huhtamäki Oy Procede de fabrication de capsules sous-cutanees
US5230207A (en) * 1991-03-28 1993-07-27 Rolf Hartzell Equipment for manufacturing of subcutaneous capsules
US5261211A (en) * 1991-03-28 1993-11-16 Huntamaki Oy Method for manufacturing of subcutaneous capsules

Also Published As

Publication number Publication date
NL181904B (nl) 1987-07-01
DK150812C (da) 1987-12-21
FI781593A (fi) 1978-11-21
RO84527A2 (fr) 1984-06-21
ES469989A1 (es) 1979-09-16
ATA365978A (de) 1981-01-15
BG31064A3 (en) 1981-10-15
NL181904C (nl) 1987-12-01
ES242664Y (es) 1980-04-01
CH624900A5 (fr) 1981-08-31
GB1597303A (en) 1981-09-03
DE2722806A1 (de) 1978-11-23
SE442166B (sv) 1985-12-09
US4247006A (en) 1981-01-27
YU150182A (en) 1989-02-28
CA1100873A (fr) 1981-05-12
BE867233A (fr) 1978-09-18
AR221842A1 (es) 1981-03-31
SE7805760L (sv) 1978-11-21
CS205123B2 (en) 1981-04-30
MX5217E (es) 1983-04-25
FR2390947B1 (fr) 1980-04-04
ES242665Y (es) 1980-04-01
DE2722806C2 (de) 1984-12-13
TR19872A (tr) 1980-04-03
YU121678A (en) 1983-02-28
NO146456B (no) 1982-06-28
PT68059A (en) 1978-06-01
NL7805393A (nl) 1978-11-22
YU45543B (en) 1992-05-28
ES242664U (es) 1979-10-16
FI68969C (fi) 1985-12-10
DK150812B (da) 1987-06-29
GR64534B (en) 1980-04-10
JPS53145908A (en) 1978-12-19
SU1127524A3 (ru) 1984-11-30
AU3626278A (en) 1979-11-22
PT68059B (en) 1979-10-26
IE46974B1 (en) 1983-11-16
FI68969B (fi) 1985-08-30
DD135469A5 (de) 1979-05-09
IT7849462A0 (it) 1978-05-19
IT1103484B (it) 1985-10-14
IE781008L (en) 1978-11-20
AU521515B2 (en) 1982-04-08
ES242665U (es) 1979-10-16
PL206968A1 (pl) 1979-02-12
JPS6323172B2 (fr) 1988-05-16
AT363605B (de) 1981-08-25
PL114266B1 (en) 1981-01-31
RO84527B1 (ro) 1984-08-30
NO146456C (no) 1982-10-06
EG14108A (en) 1983-03-31
BR7803155A (pt) 1979-01-09
ZA782874B (en) 1979-06-27
HU178486B (en) 1982-05-28
NO781743L (no) 1978-11-21
DK199878A (da) 1978-11-21

Similar Documents

Publication Publication Date Title
FR2390947A1 (fr) Corps de capsule en particulier pour l'utilisation avec une capsule assemblee pour une preparation pharmaceutique, procede et appareil pour sa fabrication
NL7712567A (nl) Werkwijze ter bereiding van trigesubstitueerde 1-fenyl-2,3,4,5-tetrahydro-1h-3-benzazepine verbindingen, alsmede farmaceutische prepara- ten die deze verbindingen als actieve component bevatten.
BG102808A (en) Method for filling of medicamentous capsules and product, prepared by it
DE3869114D1 (de) Fluessigkristallverbindung und gemische, die diese verbindung enthalten.
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
NL7507268A (nl) Werkwijze ter bereiding van 1(alpha),24-dihydroxy-chole- calciferolen, alsmede derivaten en voorlopers daar- van , alsmede farmaceutische preparaten die deze ver- bindingen als actieve componenten bevatten.
CA2111987A1 (fr) Recipient pour medicament
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
MY103500A (en) Pouring device
IT7830651A0 (it) Colonna per l'eliminazione di veleni e/o altre sostanze da una miscela liquida e/o per lo scambio ionico.
EP0371283A3 (fr) Stabilisation d'iophore emballé et minimalisation de la perte d'iode à travers l'emballage
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
BG95330A (bg) Контрастни средства
DE3873016D1 (de) Optisch aktive, delta-valerolacton-ring enthaltende verbindung und dieselbe enthaltende fluessigkristalline zusammensetzung.
BG104527A (en) Formulations comprising dissolved paroxetine
NL7609559A (nl) Werkwijze ter bereiding van oxazolidinonen alsmede geneeskrachtige middelen die deze ver- bindingen als actieve component bevatten.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
BE845709R (fr) Composition pharmaceutique contenant du 1, 3-bis (2-carboxychromone-5-yloxy)-2-hydroxypropane pour le traitement de l'ulcere de la bouche
NL7702757A (nl) Werkwijze voor de bereiding van nieuwe 17-spirosultineverbindingen en overeenkomstige gam- ma-hydroxyzuren daarvan, werkwijze voor de bereiding van farmaceutische preparaten die deze stoffen bevat- ten, alsmede farmaceutische preparaten verkregen volgens deze werkwijze.
NL7607494A (nl) Werkwijze ter bereiding van 2-benzopyranonderi- vaten alsmede geneeskundige preparaten die deze verbindingen als actieve component bevatten.
NL7608319A (nl) Werkwijze ter bereiding van 1,2,3,4-tetrahydro- -isochinolinen, alsmede farmaceutische prepa- raten die deze verbindingen als actieve compo- nent bevatten.
NL7709466A (nl) Werkwijze ter bereiding van cefalosporinen, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
JPH0715552Y2 (ja) 注射器型2成分分封容器
IT1094899B (it) 4-fenil-8-amino-tetraidroisochinoline,preparati farmaceutici contenenti tali sostanze,processo per la preparazione di questi preparati e loro impiego come antide pressivi
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.

Legal Events

Date Code Title Description
TP Transmission of property